NASDAQ$BTTC

Black Titan Corp · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Headline financials

Total Revenue

$83K

Previous: $76.7K+8.3%
EPS (adj)

-$2.20

Previous: -$3.60+38.9%
Net Income

-$1.59M

Previous: -$261K-507.4%
Operating Income

-$1.59M

Previous: -$261K-508.6%
Gross Profit

-$441K

Previous: $76.7K-675.2%
Cash & Equivalents

$105K

Previous: $6.42M-98.4%
Total Assets

$812K

Previous: $8.32M-90.2%
Stock-Based Comp

$264K

Previous: $244K+8.2%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$83K

Q2 2023+8.3%vs Q2 2022
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro